Sermorelin injections replace a hormone signal your pituitary stopped sending clearly, not the growth hormone itself. This guide breaks down who should consider sermorelin injections for adult growth hormone deficiency (AGHD) in 2026, what actually separates a real protocol from a compounding-pharmacy gamble, and where the injection format beats the alternatives.
TL;DR
Sermorelin injections are a growth hormone-releasing hormone (GHRH) analog used to treat confirmed adult growth hormone deficiency, typically dosed nightly by subcutaneous injection with IGF-1 bloodwork checked every 4-6 weeks. The standard nightly protocol is the Buy for adults with a documented low IGF-1 or a failed stimulation test; a sermorelin plus ipamorelin stack is a reasonable Consider for people already stable on sermorelin alone; unlicensed high-dose compounded sermorelin sold without bloodwork is a hard Skip in 2026. Rebody Health runs this through licensed clinician review before anything ships.
Why this matters
Adult-onset GH deficiency doesn't look dramatic. It looks like low energy, stalled recovery from workouts, softer sleep, and body composition that won't respond to diet changes the way it used to. Sermorelin doesn't force GH production the way synthetic hGH does — it prompts your own pituitary to release it in a pulse, which is why the injection timing and half-life actually matter to your results.
Most people asking about sermorelin injections in 2026 are 35-65, have had bloodwork already flag low IGF-1, and want something that works with their own physiology instead of overriding it. That distinction is the whole reason to pick sermorelin over synthetic growth hormone in the first place.
Who sermorelin injections are for
This is for adults with a documented growth hormone deficiency diagnosis — a peak GH under roughly 5.1 ng/mL on a stimulation test, or a low age-adjusted IGF-1 on standard labs — who want a GHRH-based approach rather than direct synthetic hGH. It is not for someone chasing a vague sense of low energy with no labs behind it, and it's not a shortcut for people who haven't had a stimulation test or IGF-1 panel run in the past year.
What to look for in sermorelin injections for adults
Confirmed deficiency, not a hunch
A legitimate sermorelin protocol starts with labs, not a symptom checklist. If a provider offers sermorelin injections without asking for IGF-1 or a GH stimulation test first, that's a red flag, not a shortcut — dosing without a baseline means you can't tell if it's working.
Injection frequency and half-life
Sermorelin has a short half-life of roughly 10-12 minutes, so it's typically injected once nightly, timed to coincide with the body's natural GH pulse during early sleep. A protocol that ignores timing and tells you to dose whenever is skipping the part that makes sermorelin work.
IGF-1 monitoring built into the plan
Results get measured in IGF-1, not in how you feel week one. A real plan rechecks labs at 4-6 weeks and again around 12 weeks to confirm the dose is doing something measurable, not just billing you on autopilot.
Clinician access after the first dose
Side effects like injection-site redness or mild water retention show up early for some people. You want a licensed clinician review process that lets you ask questions after week one, not a one-and-done intake form. The same standard applies across hormone care broadly — menopause hormone therapy clinics are judged on identical criteria: clinician access between appointments and dose decisions anchored to bloodwork rather than a fixed schedule.
Stack compatibility
Sermorelin is frequently paired with a GHRP like ipamorelin to broaden the GH pulse. If you're considering a stack, the protocol should say so explicitly and monitor accordingly — stacking without adjusting monitoring is how people miss side effects.
Format flexibility
Injections aren't the only delivery method. A sermorelin nasal spray comparison is worth reading before you commit to needles, especially if daily injection is the dealbreaker keeping you from starting at all.
Top picks
The baseline pick — nightly subcutaneous sermorelin alone. Standard dose runs on a once-nightly injection timed before sleep, with IGF-1 rechecked at 4-6 weeks. This is the protocol most adults with confirmed AGHD start on in 2026, and it's the easiest to monitor because there's only one variable. Buy if your labs confirm deficiency and you're comfortable with a daily subcutaneous injection.
The accelerator — sermorelin plus ipamorelin. Adding a GHRP to GHRH-based sermorelin broadens the GH pulse rather than just extending it. People already stable on sermorelin alone sometimes add this after a 12-week checkpoint if IGF-1 gains have plateaued. Consider it only after you have a baseline sermorelin response to compare against — starting both at once makes it impossible to know what's doing the work.
The needle-free alternative — sermorelin nasal spray. Same GHRH mechanism, different delivery, and it removes the daily-injection barrier that stops a lot of people from starting at all. Absorption and consistency differ from subcutaneous dosing, which is exactly what the sermorelin nasal spray comparison walks through. Consider if injection frequency is the actual reason you haven't started treatment.
The wildcard to skip — unlicensed high-dose compounded sermorelin. Sold online with no lab requirement and doses well above standard nightly ranges, marketed on "faster results." There's no monitoring built in, no IGF-1 recheck, and no clinician follow-up when side effects show up. Skip it — in 2026, this is still the most common way people get burned on peptide therapy generally, not just sermorelin.
What to avoid
- Sermorelin sold with no lab intake. If nobody asks for IGF-1 or a stimulation test, you're not being treated, you're being sold a peptide.
- Protocols with no recheck schedule. A plan that never retests IGF-1 has no way to prove it's working or catch a dose that's too low.
- Synthetic hGH marketed as "the same thing but stronger." It isn't the same mechanism, it isn't dosed the same way, and it isn't appropriate for someone who hasn't tried a GHRH approach first.
Verdict comparison
| Pick | Delivery | Frequency | Monitoring | Verdict |
|---|---|---|---|---|
| Sermorelin alone | Subcutaneous injection | Nightly | IGF-1 at 4-6 weeks | Buy |
| Sermorelin + ipamorelin | Subcutaneous injection | Nightly | IGF-1 at 4-6 and 12 weeks | Consider |
| Sermorelin nasal spray | Intranasal | Nightly | IGF-1 at 4-6 weeks | Consider |
| Unlicensed high-dose compounded | Injection, no oversight | Variable | None | Skip |
FAQ
Is sermorelin the same as HGH? No — sermorelin is a GHRH analog that prompts your pituitary to release its own growth hormone, while synthetic HGH is the hormone itself, injected directly. That mechanism difference is why sermorelin protocols lean on IGF-1 monitoring rather than direct hormone measurement.
How long does it take to see results from sermorelin injections? Most protocols recheck IGF-1 at 4-6 weeks, and that's typically the earliest point you'd see a measurable lab change. Subjective changes in sleep and recovery often show up before the first recheck, but the lab number is what confirms it's working.
What's the difference between sermorelin injections and the nasal spray? Both use the same GHRH mechanism, but injections are dosed subcutaneously while the nasal spray is intranasal — delivery and absorption differ, which is covered in the sermorelin nasal spray comparison. Injection remains the more established route for adults with confirmed AGHD as of 2026.
Do I need a diagnosis to start sermorelin injections? Yes — a legitimate protocol requires a documented low IGF-1 or a GH stimulation test showing peak GH below roughly 5.1 ng/mL before dosing starts. Any provider skipping that step is not running a real AGHD protocol.
Can sermorelin be combined with ipamorelin safely? It's a common combination, but it should be added after a baseline sermorelin-alone response, not started simultaneously. Combining GHRH and GHRP compounds without a monitoring plan makes it harder to isolate side effects.
What are the common side effects of sermorelin injections? Injection-site redness, mild flushing, and occasional headache are the most commonly reported effects. Most resolve within the first few weeks and are one reason ongoing clinician access matters more than a one-time intake form.
How is sermorelin dosed — daily or weekly? Sermorelin's short half-life of roughly 10-12 minutes means it's typically dosed nightly rather than weekly, timed around the body's natural sleep-linked GH pulse. Weekly dosing schedules for a GHRH this short-acting generally aren't standard practice.
Is sermorelin legal and prescription-only in the US? Yes — legitimate sermorelin therapy in the US requires a prescription following lab-confirmed deficiency, dispensed through a licensed pharmacy. Sermorelin sold without any prescription requirement or lab intake falls outside that standard.
One last thing
The detail most people miss: sermorelin's 10-12 minute half-life isn't a downside, it's the entire point. It clears fast enough that your pituitary still does the actual work of releasing GH in its natural pulse pattern, timed to sleep, instead of a synthetic hormone flooding your system on a schedule that has nothing to do with your own physiology. That's the mechanism difference that separates a nightly sermorelin protocol from synthetic hGH — and it's why the timing of the injection matters as much as the dose itself heading into 2026.